LOLC has reportedly defended a proposed Rs. 20 billion credit facility involving People’s Bank by citing foreign currency collateral. However, questions concerning the facility’s status, actual borrowing, pledged deposits and regulatory treatment remain unresolved.
COLOMBO — A reported Rs. 20 billion credit facility involving People’s Bank and the LOLC Group has come under renewed scrutiny following competing accounts of the proposed transaction, with questions remaining over whether the facility was approved or activated, how much money was actually borrowed and the value of the US dollar deposits reportedly pledged as collateral.
The controversy centres on a document attributed to the board of LOLC Mauritius Holdings, dated September 4, 2026, which reportedly refers to a financing arrangement involving the State-owned bank.
According to the source material reviewed by The Morning Telegraph, LOLC subsequently issued a statement maintaining that the proposed credit facility was fully secured by a foreign currency deposit.
The group reportedly explained that borrowing in Sri Lankan rupees against foreign currency assets, without first converting those assets into local currency, is an established practice in international finance.
Such financing structures are not inherently improper. Banks may provide credit against deposits or other acceptable collateral, subject to regulatory requirements, credit assessments and appropriate internal approvals.
Nevertheless, the existence of collateral does not, by itself, establish whether a particular facility was approved, how much was disbursed or whether all applicable banking regulations were satisfied.
The reported transaction therefore presents four matters requiring clarification from LOLC, People’s Bank and, where relevant, the Central Bank of Sri Lanka.
The Morning Telegraph has not independently authenticated the alleged September 4 board document or obtained the complete original statements attributed to the institutions concerned. The reported claims are therefore examined as matters requiring documentary confirmation, rather than established evidence of financial misconduct.
1. Why Do the Reported Accounts of LOLC and People’s Bank Differ?
The first issue concerns an apparent discrepancy between information attributed to LOLC and statements reportedly made by the Chairman of People’s Bank.
According to the supplied material, the bank’s Chairman previously told a media conference that the contents of a document attributed to LOLC Mauritius Holdings, dated September 4, 2026, did not correspond with information held by People’s Bank.
He was also reported to have said that the bank had not, at that time, granted the loan described in the document.
That distinction is important.
An internal company resolution authorising management to seek or negotiate financing is not necessarily evidence that a commercial bank has approved the facility, entered into a binding agreement or disbursed funds.
Similarly, a bank’s denial that a loan has been granted does not automatically establish that discussions, preliminary approvals or financing proposals never existed.
It is therefore necessary to establish precisely what the disputed board document records.
Does it authorise a proposed borrowing arrangement, refer to an approved credit line or describe an existing facility?
If LOLC’s statement concerns the same transaction, does it refer to an arrangement already concluded or one that remained under negotiation when People’s Bank’s Chairman addressed the media?
The answers would help determine whether the apparently conflicting statements represent a genuine factual disagreement or different descriptions of separate stages in a financing process.
People’s Bank and LOLC should be given an opportunity to clarify the position by identifying the status and relevant dates of the transaction.
People’s Bank LOLC loan claims involving a proposed Rs. 20 billion facility raise questions over collateral, exposure limits and regulatory oversight.
Read More2. How Much of the Rs. 20 Billion Has Actually Been Borrowed?
The second question concerns the amount of credit, if any, that has been drawn down.
A facility worth up to Rs. 20 billion does not necessarily mean that the borrower has received Rs. 20 billion.
Commercial banking arrangements commonly distinguish between an approved facility limit, the amount available for borrowing and the outstanding balance actually utilised.
The source material states that LOLC’s reported explanation concentrated on the foreign currency collateral supporting the proposed facility without specifying how much had been borrowed.
If accurate, this omission leaves an important distinction unresolved.
Was the Rs. 20 billion facility merely proposed, approved but unused, partially drawn down or fully utilised?
If no funds had been disbursed, confirmation of that position would materially clarify the nature of the reported transaction.
Conversely, if money had already been advanced, the dates and amounts of disbursement would be relevant to determining the bank’s exposure and the financial obligations created.
The significance of this information extends beyond the headline value of the facility.
A bank’s credit commitment, actual outstanding lending and associated collateral arrangements can have different implications for liquidity management, risk exposure and regulatory reporting.
Neither the reported existence of a large facility nor the claim that it is fully secured establishes the amount of money actually borrowed.
Clarifying that figure would help distinguish a proposed financing arrangement from a completed lending transaction.
3. What Is the Actual Value of the Dollar Collateral?
LOLC’s reported statement that the facility is fully secured by a US dollar deposit introduces a third question: what is the value of that deposit, and where is it held?
The source material estimates that fully covering a Rs. 20 billion facility would require foreign currency collateral equivalent to approximately US$65 million to US$70 million at the exchange rates contemplated in the original report.
That estimate is indicative rather than a verified valuation.
The precise amount would depend on the exchange rate used, collateral valuation policies, applicable margins, currency fluctuations and the specific contractual terms.
A deposit equivalent to the rupee value of a facility may also be subject to additional security requirements or valuation discounts.
More importantly, the assertion that collateral exists does not establish that it has been independently verified, legally pledged or placed under the lender’s enforceable control.
Those distinctions matter when assessing the strength of a secured lending arrangement.
If the deposit is held at People’s Bank, the bank and borrower should be able to confirm, subject to applicable confidentiality requirements, whether sufficient collateral was established and accepted under the relevant credit agreement.
Other questions concern the ownership of the deposit, the entity legally pledging it, the currency in which it is denominated and whether the bank has an enforceable right to apply the collateral in the event of default.
There may also be legitimate commercial reasons for borrowing locally while retaining foreign currency holdings.
A business might wish to avoid converting dollar assets into rupees or may require domestic liquidity while preserving foreign currency funds for other obligations.
Such an arrangement is not inherently evidence of wrongdoing.
The public-interest issue is whether the reported collateral adequately supports the proposed facility and whether the transaction complies with the bank’s credit policies and applicable regulations.
4. Were Central Bank Large-Exposure Rules Satisfied?
The fourth issue concerns the regulatory treatment of a credit facility of this size.
Sri Lanka’s Central Bank introduced Banking Act Directions No. 01 of 2024 on the large exposures of licensed banks, establishing requirements intended to limit excessive credit concentration and protect the stability of the banking system.
The framework addresses exposures to individual counterparties and groups of connected counterparties, among other matters.
Importantly, the Central Bank issued amendments to those directions on September 24, 2026, through Banking Act Directions No. 05 of 2026.
Any assessment of the alleged LOLC transaction must therefore consider the applicable regulatory provisions, their commencement dates, the treatment of eligible collateral and the bank’s relevant capital position.
A facility of Rs. 20 billion cannot be declared non-compliant merely because its nominal value appears substantial.
Determining whether exposure limits have been breached would require information about the bank’s regulatory capital, its exposure to the borrower and related entities, the applicable calculation methodology, permitted credit-risk mitigation and any relevant supervisory approvals or exceptions.
Foreign currency collateral may affect how certain risks are assessed, but its existence should not be assumed either to eliminate regulatory exposure or to constitute a breach.
The relevant questions are whether the facility, if approved, was assessed under the correct regulatory framework and whether the bank satisfied its internal and supervisory obligations.
The Central Bank’s Bank Supervision Department is responsible for overseeing compliance with applicable banking requirements.
While individual supervisory records and customer-specific information may be subject to confidentiality restrictions, the regulator can clarify the general legal requirements governing large secured exposures and any applicable exceptions.
There is no verified evidence in the supplied material establishing that People’s Bank breached the Central Bank’s exposure limits.
The regulatory question therefore remains one of compliance verification, not a demonstrated violation.
Legal Warnings and the Right to Question State Bank Transactions
The source material also alleges that LOLC warned of possible legal action against parties publishing information about the reported financing arrangement.
The exact wording and context of any such warning have not been independently established.
Companies are entitled to challenge inaccurate reporting, protect confidential commercial information and seek legal remedies where appropriate.
Those rights coexist with the media’s responsibility to report accurately on matters of legitimate public interest, including significant transactions involving State-owned financial institutions.
A report concerning a proposed credit facility at People’s Bank should therefore be assessed on the strength of verifiable evidence, not solely on the competing assertions of the parties involved.
Public scrutiny does not establish that a transaction is improper, just as a company’s assurance that financing is fully secured does not independently verify every element of the arrangement.
The distinction is particularly important where allegations concern a bank entrusted with public deposits and operating within Sri Lanka’s regulated financial system.
Transparency must also be balanced against legitimate banking confidentiality.
Not every commercially sensitive document or customer-specific financial record can necessarily be disclosed publicly. Nevertheless, accurate clarification of the transaction’s status, applicable safeguards and regulatory compliance would help address the questions arising from the reported statements.
Four Matters Requiring Documentary Clarification
The central issues surrounding the alleged Rs. 20 billion facility can be reduced to four questions:
1. Transaction status: Was a credit facility proposed, formally approved, contracted or activated, and how does that status correspond with the reported statements of People’s Bank’s Chairman?
2. Actual borrowing: How much of the Rs. 20 billion facility, if any, has been disbursed, and what amount remains outstanding?
3. Collateral: What is the verified value of the pledged US dollar deposit, which entity owns it, where is it held and how has its adequacy been assessed?
4. Regulatory compliance: How was the proposed facility treated under the Central Bank’s large-exposure requirements, including the applicable 2024 directions and subsequent amendments?
Further information would also help establish the dates of any relevant credit approvals, the lending entity’s contractual relationship with LOLC Mauritius Holdings and the basis for describing the facility as fully secured.
None of these questions presupposes that either institution acted improperly.
They concern the accuracy of statements made about a substantial financing arrangement and the processes through which such arrangements are assessed.
Public Confidence Requires Verifiable Answers
The reported dispute highlights the importance of distinguishing internal corporate authorisations, bank credit approvals, actual borrowing and the collateral supporting a financial facility.
Each represents a separate element of the lending process.
A board resolution may authorise a company to obtain financing without establishing that the bank agreed to provide it. An approved credit line may remain unused. A secured loan may comply with banking regulations, provided the necessary requirements are satisfied.
These distinctions are essential to understanding the reported LOLC and People’s Bank transaction.
Equally, uncertainty over the status of a significant facility should not be allowed to develop into unsupported accusations against financial institutions or their officials.
The Morning Telegraph has not established that Rs. 20 billion was disbursed, that People’s Bank granted a facility contrary to regulatory requirements or that the reported collateral was inadequate.
What remains unresolved is whether the accounts attributed to LOLC and People’s Bank describe the same financing arrangement and, if so, how their respective explanations can be reconciled.
Documented clarification from the institutions concerned, accompanied where appropriate by an explanation of the relevant regulatory requirements, would help settle those questions without compromising legitimate commercial confidentiality.
Until then, the reported Rs. 20 billion facility remains a matter requiring further verification, with its approval status, utilisation, collateral and regulatory treatment central to establishing the facts.
